Comparison of Meta-Analyses of Therapeutic Studies on Regression of Left Ventricular Hypertrophy

  • Lennart Hansson
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 432)


In recent years several meta-analyses have been performed of studies in which the effect of various antihypertensive therapies on left ventricular hypertrophy (LVH) has been assessed. It is the purpose of this review to briefly discuss three of these meta-analyses. All data in the reviewed studies have been obtained with the echocardiographic technique.


Left Ventricular Hypertrophy Angiotensin Converting Enzyme Inhibitor Antihypertensive Therapy Framingham Heart Study Echocardiographic Technique 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Levy D. Left ventricular hypertrophy. Epidemiological insights from the Framingham Heart Study. Drugs 1998; 35(suppl 5):l–5.Google Scholar
  2. 2.
    Levy D, Garrison RJ, Sagae DD et al. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990; 322:1561–1566.PubMedCrossRefGoogle Scholar
  3. 3.
    Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients. A metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5:95–110.PubMedGoogle Scholar
  4. 4.
    Schmieder RE, Martus P, Klingbeil A. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies. JAMA 1996; 275:1507–1513.PubMedCrossRefGoogle Scholar
  5. 5.
    Jennings GL, Wong J. Reversibility of left ventricular hypertrophy and malfunction by antihypertensive treatment. In: Handbook of Hypertension, Vol 18, Assessment of Hypertensive Organ Damage. Eds: Hansson L, Birkenhäger WH. Elsevier, Rotterdam 1997; 184–223.Google Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Lennart Hansson
    • 1
  1. 1.Division of Clinical Hypertension Research, Department of GeriatricsUniversity of UppsalaUppsalaSweden

Personalised recommendations